Detalhe da pesquisa
1.
The IRE1α-endonuclease plays a dual role in regulating the XBP1/miRNA-34a axis and PD-1 expression within Natural Killer cells in Hodgkin Lymphoma.
Acta Haematol
; 2024 Mar 13.
Artigo
Inglês
| MEDLINE | ID: mdl-38479365
2.
A coordinated strategy for a simple, pragmatic approach to the early identification of the ultra-high-risk patient with diffuse large B-cell lymphoma.
Intern Med J
; 53(7): 1105-1109, 2023 07.
Artigo
Inglês
| MEDLINE | ID: mdl-37032307
3.
Successful treatment of Epstein-Barr virus-associated primary central nervous system lymphoma due to post-transplantation lymphoproliferative disorder, with ibrutinib and third-party Epstein-Barr virus-specific T cells.
Am J Transplant
; 21(10): 3465-3471, 2021 10.
Artigo
Inglês
| MEDLINE | ID: mdl-33942495
4.
EBV microRNA-BHRF1-2-5p targets the 3'UTR of immune checkpoint ligands PD-L1 and PD-L2.
Blood
; 134(25): 2261-2270, 2019 12 19.
Artigo
Inglês
| MEDLINE | ID: mdl-31856276
5.
Somatic IL4R mutations in primary mediastinal large B-cell lymphoma lead to constitutive JAK-STAT signaling activation.
Blood
; 131(18): 2036-2046, 2018 05 03.
Artigo
Inglês
| MEDLINE | ID: mdl-29467182
6.
Biology and therapy of primary mediastinal B-cell lymphoma: current status and future directions.
Br J Haematol
; 185(1): 25-41, 2019 04.
Artigo
Inglês
| MEDLINE | ID: mdl-30740662
7.
The tumour microenvironment is immuno-tolerogenic and a principal determinant of patient outcome in EBV-positive diffuse large B-cell lymphoma.
Eur J Haematol
; 103(3): 200-207, 2019 Sep.
Artigo
Inglês
| MEDLINE | ID: mdl-31211907
8.
Genomic rearrangements involving programmed death ligands are recurrent in primary mediastinal large B-cell lymphoma.
Blood
; 123(13): 2062-5, 2014 Mar 27.
Artigo
Inglês
| MEDLINE | ID: mdl-24497532
9.
Whole transcriptome sequencing reveals recurrent NOTCH1 mutations in mantle cell lymphoma.
Blood
; 119(9): 1963-71, 2012 03 01.
Artigo
Inglês
| MEDLINE | ID: mdl-22210878
10.
Elevated circulating tissue factor procoagulant activity, factor VII, and plasminogen activator inhibitor-1 in childhood obesity: evidence of a procoagulant state.
Br J Haematol
; 158(4): 523-7, 2012 Aug.
Artigo
Inglês
| MEDLINE | ID: mdl-22612792
11.
Intratumoral T-cell receptor repertoire is predictive of interim PET scan results in patients with diffuse large B-cell lymphoma treated with rituximab/cyclophosphamide/doxorubicin/prednisolone/vincristine (R-CHOP) chemoimmunotherapy.
Clin Transl Immunology
; 10(11): e1351, 2021.
Artigo
Inglês
| MEDLINE | ID: mdl-34745610
12.
Intratumoral T cells have a differential impact on FDG-PET parameters in follicular lymphoma.
Blood Adv
; 5(12): 2644-2649, 2021 06 22.
Artigo
Inglês
| MEDLINE | ID: mdl-34156439
13.
Correction for Massari et al., meningococcal porin PorB prevents cellular apoptosis in a Toll-like receptor 2- and NF-κB-independent manner.
Infect Immun
; 83(8): 3339, 2015 Aug.
Artigo
Inglês
| MEDLINE | ID: mdl-26157088
14.
Meningococcal porin PorB prevents cellular apoptosis in a toll-like receptor 2- and NF-kappaB-independent manner.
Infect Immun
; 78(3): 994-1003, 2010 Mar.
Artigo
Inglês
| MEDLINE | ID: mdl-20028813
15.
Genetic aberrations of NLRC5 are associated with downregulated MHC-I antigen presentation and impaired T-cell immunity in follicular lymphoma.
EJHaem
; 1(2): 517-526, 2020 Nov.
Artigo
Inglês
| MEDLINE | ID: mdl-35845006
16.
Cathepsin S Alterations Induce a Tumor-Promoting Immune Microenvironment in Follicular Lymphoma.
Cell Rep
; 31(5): 107522, 2020 05 05.
Artigo
Inglês
| MEDLINE | ID: mdl-32330423
17.
Progression of Disease Within 24 Months in Follicular Lymphoma Is Associated With Reduced Intratumoral Immune Infiltration.
J Clin Oncol
; 37(34): 3300-3309, 2019 12 01.
Artigo
Inglês
| MEDLINE | ID: mdl-31461379
18.
Reply to M. Sorigue.
J Clin Oncol
; 38(6): 648-649, 2020 02 20.
Artigo
Inglês
| MEDLINE | ID: mdl-31815583
19.
Recurrent somatic mutations of PTPN1 in primary mediastinal B cell lymphoma and Hodgkin lymphoma.
Nat Genet
; 46(4): 329-35, 2014 Apr.
Artigo
Inglês
| MEDLINE | ID: mdl-24531327
20.
Whole-blood tissue factor procoagulant activity is elevated in type 1 diabetes: effects of hyperglycemia and hyperinsulinemia.
Diabetes Care
; 35(6): 1322-7, 2012 Jun.
Artigo
Inglês
| MEDLINE | ID: mdl-22410811